Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.
Cells. 2022 Apr 22;11(9):1415. doi: 10.3390/cells11091415.
Cells. 2022.
PMID: 35563721
Free PMC article.
Review.
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.
Ioannou K, Cheng KF, Crichlow GV, Birmpilis AI, Lolis EJ, Tsitsilonis OE, Al-Abed Y.
Ioannou K, et al. Among authors: birmpilis ai.
Int J Oncol. 2014 Oct;45(4):1457-68. doi: 10.3892/ijo.2014.2551. Epub 2014 Jul 22.
Int J Oncol. 2014.
PMID: 25050663
Free PMC article.
Item in Clipboard
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.
Birmpilis AI, Karachaliou CE, Samara P, Ioannou K, Selemenakis P, Kostopoulos IV, Kavrochorianou N, Kalbacher H, Livaniou E, Haralambous S, Kotsinas A, Farzaneh F, Trougakos IP, Voelter W, Dimopoulos MA, Bamias A, Tsitsilonis O.
Birmpilis AI, et al.
Cancers (Basel). 2019 Nov 9;11(11):1764. doi: 10.3390/cancers11111764.
Cancers (Basel). 2019.
PMID: 31717548
Free PMC article.
Item in Clipboard
Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo Investigation.
Birmpilis AI, Vitsos P, Kostopoulos IV, Williams L, Ioannou K, Samara P, Karachaliou CE, Voutsas IF, Alyfanti E, Angelis N, Gavalas NG, Gkraikou T, Kappa N, Klagkou E, Klimentzou P, Nikou S, Papaioannou NE, Skopeliti M, Toukli D, Dimopoulos MA, Bamias A, Livaniou E, Kalbacher H, Tsitsilonis OE, Voelter W.
Birmpilis AI, et al.
Curr Med Chem. 2022;29(42):6463-6478. doi: 10.2174/0929867328666211117093401.
Curr Med Chem. 2022.
PMID: 34789121
Item in Clipboard
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients.
Kostopoulos IV, Kakalis A, Birmpilis A, Angelis N, Orologas-Stavrou N, Rousakis P, Panteli C, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Tsitsilonis O, Terpos E.
Kostopoulos IV, et al.
Am J Hematol. 2023 Mar;98(3):E65-E67. doi: 10.1002/ajh.26823. Epub 2022 Dec 30.
Am J Hematol. 2023.
PMID: 36565455
Free article.
No abstract available.
Item in Clipboard
Cite
Cite